GPEN 2002 Keynote Speaker
Arthur Franke, Ph.D., is Sr. Research Director in Molecular Sciences and Technologies at Pfizer Global Research and Development Laboratories in Ann Arbor, MI. In this role, Dr. Franke currently oversees drug discovery programs in Bioinformatics, Expression Profiling, Proteomics, and Biomarkers. Dr. Franke has been actively exploring innovative applications of molecular sciences to pharmaceutical research for the past 20 years.
Dr. Franke obtained his undergraduate and doctoral degrees in Microbiology from the University of Michigan, Ann Arbor. After completing postdoctoral research at Genentech, Inc., Dr. Franke began his career at Pfizer in Groton, CT as a Research Scientist. His career at Pfizer has been marked by strong scientific contributions beginning with genetic engineering research that generated proprietary expression cultures used to develop a commercial process for Pfizer's first product derived from recombinant DNA technology.
Dr. Franke has a long record of strong scientific leadership in the application of genetic technologies to drug discovery processes. Current research activities focus on building high quality target portfolios in psychotherapeutics, cancer, anti-bacterials and other therapeutic areas. Dr Franke has been recognized as a key contributor to several external collaborations in Pfizer’s global network of discovery technologies.